Statins may lower risk of cancer-related death in women
the ONA take:
According to results of a large study presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, researchers have found that women who take statins, medications used to treat hyperlipidemia, may have a decreased risk for cancer-related death.
For the 15-year study, researchers followed nearly 150,000 post-menopausal women aged 50 to 79 years. Over that period, more than 3,100 women died of cancer. Results showed that women who took statins had a reduced risk of dying from breast, colorectal, and ovarian cancers, but not lung cancer.
Researchers found that patients who took statins were 20% less likely to die from cancer during the study duration; however, they caution that this study does not prove a causal effect that statins reduce the lower the risk cancer-related mortality.
Further studies are warranted to determine whether it would be beneficial for women with cancer to be prescribed statins to reduce their risk of death.
Women who take statins, medications used to treat hyperlipidemia, may have a decreased risk for cancer-related death.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|